TrialThe European respiratory journal2022

Immunomodulation and endothelial barrier protection mediate the association between oral imatinib and mortality in hospitalised COVID-19 patients.

Justin de Brabander et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.